Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Delta agent: a unique hepatotropic particle.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie

|January 1, 1985

Summary

This summary is machine-generated.

The delta agent is a virus-like pathogen that infects people with hepatitis B virus. New tools like an animal model and nucleic acid probe will help understand delta-associated liver disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Frontiers in clinical immunology 2008.

Scandinavian journal of immunology·2009

Same author

A novel tissue engineering-based assay for immunological infertility.

Scandinavian journal of immunology·2008

Same author

Cellular interactions and signalling defects in lupus (1).

Lupus·2008

Same author

Paraneoplastic autoimmunity.

Polish journal of veterinary sciences·2007

Same author

Silent antibodies.

Archives de l'Institut Pasteur de Tunis·2006

Same author

[Werner's syndrome and endocrine disorders].

Annales d'endocrinologie·2003

Same journal

Wnt activation during epileptogenesis prevents pathological immature dentate granule cell morphological changes in animal models of unilateral and bilateral temporal lobe epilepsy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same journal

Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same journal

Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same journal

Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same journal

Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same journal

Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

See all related articles

Area of Science:

Virology
Hepatology
Infectious Diseases

Background:

The delta agent is a unique human pathogen.
It is a defective particle requiring hepatitis B virus for replication.
Transmission occurs through blood products and body fluids.

Purpose of the Study:

To investigate the characteristics of the delta agent.
To understand its relationship with hepatitis B virus.
To explore the pathogenesis of delta-associated liver disease.

Main Methods:

Description of an accessible animal model.
Development of a nucleic acid probe for delta agent detection.

Main Results:

An accessible animal model for delta agent research is now available.

Related Experiment Videos

A nucleic acid probe facilitates delta agent detection and study.

Conclusions:

The new tools will aid in understanding delta agent pathogenesis.
Further research is expected to elucidate delta-associated liver disease mechanisms.